AAAAAA

   
Results: 1-22 |
Results: 22
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult ethiopians from two geographic locales
Authors: Kassu, A Tsegaye, A Petros, B Wolday, D Hailu, E Tilahun, T Hailu, B Roos, MTL Fontanet, AL Hamann, D De Wit, TFR
Citation: A. Kassu et al., Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult ethiopians from two geographic locales, CL DIAG LAB, 8(6), 2001, pp. 1171-1176
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses
Authors: Notermans, DW De Jong, JJ Goudsmit, J Bakker, MR Roos, MTL Nijholt, L Cremers, J Hellings, JA Danner, SA De Ronde, A
Citation: Dw. Notermans et al., Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses, AIDS RES H, 17(11), 2001, pp. 1003-1008
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
Authors: Van Praag, RME Prins, JM Roos, MTL Schellekens, PTA Ten Berge, IJM Yong, SL Schuitemaker, H Eerenberg, AJM Jurriaans, S De Wolf, F Fox, CH Goudsmit, J Miedema, F Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226
The ADAM study continued: maintenance therapy after 50 weeks of induction therapy
Authors: Reijers, MHE Weverling, GJ Jurriaans, S Roos, MTL Wit, FWNM Weigel, HM Ten Kate, RW Mulder, JW Richter, C Ter Hofstede, HJM Sprenger, H Hoetelmans, RMW Schuitemaker, H Lange, JMA
Citation: Mhe. Reijers et al., The ADAM study continued: maintenance therapy after 50 weeks of induction therapy, AIDS, 15(1), 2001, pp. 129-131
Active MRI lesion appearance in MS patients is preceded by fluctuations incirculating T-helper 1 and 2 cells
Authors: Killestein, J Rep, MHG Barkhof, F Roos, MTL Ader, HJ van Lier, RAW Polman, CH
Citation: J. Killestein et al., Active MRI lesion appearance in MS patients is preceded by fluctuations incirculating T-helper 1 and 2 cells, J NEUROIMM, 118(2), 2001, pp. 286-294
Phenotypical and functional analysis of T cells in periodontitis
Authors: Petit, MDA Hovenkamp, E Hamann, D Roos, MTL van der Velden, U Miedema, F Loos, BG
Citation: Mda. Petit et al., Phenotypical and functional analysis of T cells in periodontitis, J PERIOD RE, 36(4), 2001, pp. 214-220
Nonradioactive techniques for measurement of in vitro T-cell proliferation: Alternatives to the [H-3]thymidine incorporation assay
Authors: Messele, T Roos, MTL Hamann, D Koot, M Fontanet, AL Miedema, F Schellekens, PTA de Vit, TFR
Citation: T. Messele et al., Nonradioactive techniques for measurement of in vitro T-cell proliferation: Alternatives to the [H-3]thymidine incorporation assay, CL DIAG LAB, 7(4), 2000, pp. 687-692
Changes in the composition of circulating CD8(+) T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans
Authors: Roos, MTL van Lier, RAW Hamann, D Knol, GJ Verhoofstad, I van Baarle, D Miedema, F Schellekens, PTA
Citation: Mtl. Roos et al., Changes in the composition of circulating CD8(+) T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans, J INFEC DIS, 182(2), 2000, pp. 451-458
Prognostic markers and immunological reconstitution during HIV-1 infection
Authors: Roos, MTL Pakker, NG Schellekens, PTA
Citation: Mtl. Roos et al., Prognostic markers and immunological reconstitution during HIV-1 infection, IMMUNOL MED, 28, 2000, pp. 243-259
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy
Authors: Pakker, NG Kroon, EDMB Roos, MTL Otto, SA Hall, D Wit, FWNM Hamann, D van der Ende, ME Claessen, FAP Kauffmann, RH Koopmans, PP Kroon, FP ten Napel, CHH Sprenger, HG Weigel, HM Montaner, JSG Lange, JMA Reiss, P Schellekens, PTA Miedema, F
Citation: Ng. Pakker et al., Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy, AIDS, 13(2), 1999, pp. 203-212
Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
Authors: Prins, JM Jurriaans, S van Praag, RME Blaak, H van Rij, R Schellekens, PTA ten Berge, IJM Yong, SL Fox, CH Roos, MTL de Wolf, F Goudsmit, J Schuitemaker, H Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410
Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at riskof tuberculosis
Authors: Maas, JJ Foudraine, NA Schellekens, PTA Mensen, MEAM Veenstra, J Roos, MTL van Leeuwen, R Coutinho, RA
Citation: Jj. Maas et al., Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at riskof tuberculosis, AIDS, 13(13), 1999, pp. 1784-1785
Faces and phases of human CD8(+) T-cell development
Authors: Hamann, D Roos, MTL van Lier, RAW
Citation: D. Hamann et al., Faces and phases of human CD8(+) T-cell development, IMMUNOL TOD, 20(4), 1999, pp. 177-180
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients
Authors: Rep, MHG Schrijver, HM van Lopik, T Hintzen, RQ Roos, MTL Ader, HJ Polman, CH van Lier, RAW
Citation: Mhg. Rep et al., Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients, J NEUROIMM, 96(1), 1999, pp. 92-100
Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection
Authors: Pontesilli, O Kerkhof-Garde, S Pakker, NG Notermans, DW Roos, MTL Klein, MR Danner, SA Miedema, F
Citation: O. Pontesilli et al., Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection, IMMUNOL LET, 66(1-3), 1999, pp. 213-217
Kawasaki disease: A maturational defect in immune responsiveness
Authors: Kuijpers, TW Wiegman, A van Lier, RAW Roos, MTL Wertheim-van Dillen, PME Pinedo, S Ottenkamp, J
Citation: Tw. Kuijpers et al., Kawasaki disease: A maturational defect in immune responsiveness, J INFEC DIS, 180(6), 1999, pp. 1869-1877
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
Authors: Notermans, DW Pakker, NG Hamann, D Foudraine, NA Kauffmann, RH Meenhorst, PL Goudsmit, J Roos, MTL Schellekens, PTA Miedema, F Danner, SA
Citation: Dw. Notermans et al., Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults, J INFEC DIS, 180(4), 1999, pp. 1050-1056
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
Authors: Pontesilli, O Kerkhof-Garde, S Notermans, DW Foudraine, NA Roos, MTL Klein, MR Danner, SA Lange, JMA Miedema, F
Citation: O. Pontesilli et al., Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy, J INFEC DIS, 180(1), 1999, pp. 76-86
Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function
Authors: Froebel, KS Pakker, NG Aiuti, F Bofill, M Choremi-Papadopoulou, H Economidou, J Rabian, C Roos, MTL Ryder, LP Miedema, F Raab, GM
Citation: Ks. Froebel et al., Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function, J IMMUNOL M, 227(1-2), 1999, pp. 85-97
Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterpart
Authors: Messele, T Abdulkadir, M Fontanet, AL Petros, B Hamann, D Koot, M Roos, MTL Schellekens, PTA Miedema, F De Wit, TFR
Citation: T. Messele et al., Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterpart, ETHIOP MED, 37, 1999, pp. 89-96
Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts
Authors: Messele, T Abdulkadir, M Fontanet, AL Petros, B Hamann, D Koot, M Roos, MTL Schellekens, PTA Miedema, F De Wit, TFR
Citation: T. Messele et al., Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts, CLIN EXP IM, 115(3), 1999, pp. 443-450
Risultati: 1-22 |